Chronic Venous Occlusions Treatment Market Expected To Grow From USD 10.1 Billion In 2026 To USD 18.8 Billion By 2036

(MENAFN- EIN Presswire) EINPresswire/ -- The global Chronic Venous Occlusions Treatment Market is witnessing strong growth as healthcare systems increasingly adopt minimally invasive vascular treatments. Industry analysis indicates that the market was valued at USD 9.5 billion in 2025 and is projected to reach USD 10.1 billion in 2026, eventually expanding to approximately USD 18.8 billion by 2036, growing at a compound annual growth rate (CAGR) of 7.8% during the forecast period.

Chronic venous occlusions refer to blockages in veins caused by conditions such as chronic venous insufficiency and deep vein thrombosis, leading to impaired blood flow, swelling, and pain. Treatment approaches include endovenous laser ablation, radiofrequency ablation, sclerotherapy, compression therapy, and anticoagulant medications, which aim to restore circulation and improve patient outcomes.

Get Access of Report Sample:

Rising Disease Burden and Lifestyle Factors Driving Market Growth

The increasing global prevalence of venous disorders is a major factor fueling demand for advanced treatment solutions. Aging populations, sedentary lifestyles, and rising obesity rates are significantly contributing to the growing patient pool.

Key factors driving market growth include:

Rising incidence of chronic venous diseases worldwide

Growing adoption of minimally invasive procedures

Increasing awareness and early diagnosis of venous conditions

Expansion of reimbursement coverage for vascular treatments

Technological advancements in interventional devices and therapies

Minimally invasive techniques are gaining traction due to reduced recovery time, improved safety, and enhanced clinical outcomes.

Endovenous Laser Ablation Leads Treatment Segment

Based on treatment type, endovenous laser ablation accounts for around 35% of the market share in 2026, driven by strong clinical efficacy and widespread adoption across healthcare settings.

Other key treatment options include:

Radiofrequency ablation

Sclerotherapy

Compression therapy

Pharmacological treatments

These methods are increasingly performed in outpatient and ambulatory settings, improving accessibility for patients.

Devices Segment Dominates Market

In terms of product type, devices hold approximately 54% of the market share, reflecting the growing demand for advanced medical technologies such as ablation catheters, venous stents, and imaging-guided systems.

The shift toward single-use and technologically advanced devices is further driving segment growth.

Hospitals Lead End-User Segment

By end user, hospitals account for nearly 47% of the market share, as they remain primary centers for vascular treatments and complex procedures.

However, ambulatory surgical centers (ASCs) are emerging as the fastest-growing segment due to increasing preference for outpatient procedures and cost-effective treatment options.

Regional Outlook

North America dominates the chronic venous occlusions treatment market due to advanced healthcare infrastructure and high adoption of innovative therapies. Meanwhile, Asia-Pacific is the fastest-growing region, supported by expanding healthcare investments and rising awareness in countries such as China and India.

China is projected to grow at around 7.8% CAGR, while India is expected to expand at approximately 7.0% CAGR through 2036, driven by increasing access to vascular treatments and private healthcare investments.

Competitive Landscape

The market is highly competitive, with key players focusing on innovation, product development, and strategic collaborations.

Major companies include:

Boston Scientific Corporation

Medtronic

Stryker

Cook Medical

Cardinal Health

Bayer AG

Sanofi

AngioDynamics

W. L. Gore & Associates

These companies are investing in next-generation ablation technologies, venous stents, and anticoagulant therapies to enhance treatment effectiveness.

Future Outlook

The chronic venous occlusions treatment market is expected to evolve with increasing adoption of image-guided interventions, AI-assisted diagnostics, and personalized treatment approaches.

Advancements in drug-eluting technologies, minimally invasive procedures, and outpatient care models will further transform the treatment landscape. As healthcare systems continue to focus on improving vascular care and patient outcomes, the market is poised for sustained growth over the next decade.

Browse Full Report:

Purchase Full Report for Detailed Insights

For access to full forecasts, regional breakouts, company share analysis, and emerging trend assessments, you can purchase the complete report here:

Have a specific Requirements and Need Assistant on Report Pricing or Limited Budget please contact us -...

To View Related Report:

Chronic Total Occlusion Catheter Market:

Chronic Pyelonephritis Treatment Market:

Chronic Idiopathic Constipation Treatment Market:

Pediatric Chronic Rhinosinusitis Market:

About Fact

We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client's satisfaction.

MENAFN17032026003118003196ID1110873059